OncoSec Medical Inc (ONCSQ)

[salgovernale69]

Amen. You can sign me up tomorrow for a $12 acquisition but I'd always be wondering what was left on the table. It's not at all far fetched, as you say. If you look at the sales potential of JUST MCC and Melanoma we're talking conservatively $300-$500M annually. If a normal biotech trades at 3-4x revenue than we're already at a $1.2B - $2B valuation. But, if we were to get orphan status for MCC that could warrant trading of 8-10 x revenue on the MCC piece. You can see how depending on the mix of MCC to melanoma, $3B+ is easily achievable. This doesn't even consider the new trial we'll likely be entering into this year, the cutaneous T-cell lymphoma study, neopulse, etc.

It's very easy to see how if some things broke correctly this could easily be a $5B company in 24 months. That's almost $30 a share barring further dilution folks.